2. Academic Validation
  3. Covalent targeting of the vacuolar H+-ATPase activates autophagy via mTORC1 inhibition

Covalent targeting of the vacuolar H+-ATPase activates autophagy via mTORC1 inhibition

  • Nat Chem Biol. 2019 Aug;15(8):776-785. doi: 10.1038/s41589-019-0308-4.
Clive Yik-Sham Chung 1 2,  Hijai R Shin 3 4,  Charles A Berdan 5,  Breanna Ford 5,  Carl C Ward 2 3,  James A Olzmann 5,  Roberto Zoncu 6 7,  Daniel K Nomura 8 9 10 11
Affiliations

Affiliations

  • 1 Department of Chemistry, University of California, Berkeley, Berkeley, CA, USA.
  • 2 Novartis-Berkeley Center for Proteomics and Chemistry Technologies, Berkeley, CA, USA.
  • 3 Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, USA.
  • 4 The Paul F. Glenn Center for Aging Research at the University of California, Berkeley, Berkeley, CA, USA.
  • 5 Department of Nutritional Sciences and Toxicology, University of California, Berkeley, CA, USA.
  • 6 Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, USA. rzoncu@berkeley.edu.
  • 7 The Paul F. Glenn Center for Aging Research at the University of California, Berkeley, Berkeley, CA, USA. rzoncu@berkeley.edu.
  • 8 Department of Chemistry, University of California, Berkeley, Berkeley, CA, USA. dnomura@berkeley.edu.
  • 9 Novartis-Berkeley Center for Proteomics and Chemistry Technologies, Berkeley, CA, USA. dnomura@berkeley.edu.
  • 10 Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, USA. dnomura@berkeley.edu.
  • 11 Department of Nutritional Sciences and Toxicology, University of California, Berkeley, CA, USA. dnomura@berkeley.edu.
PMID: 31285595 DOI: 10.1038/s41589-019-0308-4
Abstract

Autophagy is a lysosomal degradation pathway that eliminates aggregated proteins and damaged organelles to maintain cellular homeostasis. A major route for activating Autophagy involves inhibition of the mTORC1 kinase, but current mTORC1-targeting compounds do not allow complete and selective mTORC1 blockade. Here, we have coupled screening of a covalent ligand library with activity-based protein profiling to discover EN6, a small-molecule in vivo activator of Autophagy that covalently targets cysteine 277 in the ATP6V1A subunit of the lysosomal v-ATPase, which activates mTORC1 via the Rag guanosine triphosphatases. EN6-mediated ATP6V1A modification decouples the v-ATPase from the Rags, leading to inhibition of mTORC1 signaling, increased lysosomal acidification and activation of Autophagy. Consistently, EN6 clears TDP-43 aggregates, a causative agent in frontotemporal dementia, in a lysosome-dependent manner. Our results provide insight into how the v-ATPase regulates mTORC1, and reveal a unique approach for enhancing cellular clearance based on covalent inhibition of lysosomal mTORC1 signaling.

Figures
Products